Chennai Meenakshi Multispeciality Hospital Ltd vs Dolphin Medical Services Ltd Stock Comparison
Chennai Meenakshi Multispeciality Hospital Ltd vs Dolphin Medical Services Ltd Stock Comparison
Last Updated on: Nov 01, 2026
Key Highlights
The Latest Trading Price of Chennai Meenakshi Multispeciality Hospital Ltd is ₹ 33.15 as of 30 Oct 15:30
. The P/E Ratio of Chennai Meenakshi Multispeciality Hospital Ltd changed from 4.3 on March 2022 to 0 on March 2026 . This represents a CAGR of -100.00% over 5 yearsThe P/E Ratio of Dolphin Medical Services Ltd changed from 0 on March 2021 to 0 on March 2026 . This represents a CAGR of 0.0% over 6 years The Market Cap of Chennai Meenakshi Multispeciality Hospital Ltd changed from ₹ 7.28 crore on March 2021 to ₹ 24.66 crore on March 2026 . This represents a CAGR of 22.55% over 6 yearsThe Market Cap of Dolphin Medical Services Ltd changed from ₹ 2.25 crore on March 2021 to ₹ 0 crore on March 2026 . This represents a CAGR of -100.00% over 6 years The revenue of Chennai Meenakshi Multispeciality Hospital Ltd for the Jun '26 is ₹ 8.7 crore as compare to the Mar '26 revenue of ₹ 10.05 crore. This represent the decline of -13.43% The revenue of Dolphin Medical Services Ltd for the Jun '26 is ₹ 0.22 crore as compare to the Mar '26 revenue of ₹ 0.2 crore. This represent the growth of 10% The ebitda of Chennai Meenakshi Multispeciality Hospital Ltd for the Jun '26 is ₹ 0.46 crore as compare to the Mar '26 ebitda of ₹ 0.48 crore. This represent the decline of -4.17% The ebitda of Dolphin Medical Services Ltd for the Jun '26 is ₹ 0.04 crore as compare to the Mar '26 ebitda of ₹ 0.03 crore. This represent the growth of 33.33% The net profit of Chennai Meenakshi Multispeciality Hospital Ltd changed from ₹ -0.38 crore to ₹ 0 crore over 9 quarters. This represents a CAGR of -100.00%
The net profit of Dolphin Medical Services Ltd changed from ₹ 0.01 crore to ₹ 0.02 crore over 9 quarters. This represents a CAGR of 36.08%
The Dividend Payout of Chennai Meenakshi Multispeciality Hospital Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Dolphin Medical Services Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .
About Chennai Meenakshi Multispeciality Hospital Ltd
Chennai Meenakshi Multispeciality Hospital Limited, formerly known as Devaki Hospital Limited, was incorporated in 1990.
The Company name was changed from Devaki Hospital Limited to Chennai Meenakshi Multispeciality Hospital Limited in October, 2007.
It is a 100-bedded hospital located in the heart of Chennai at Mylapore.
The hospital has an infrastructure comprising of around 105 Beds including ICU Beds, Operating Theatre, a modern dialysis Unit besides a host of other facilities.
The Company has a pool of talented and experienced doctors who are further supported by a team of highly qualified and experienced and dedicated support staff and cutting edge technology.
The Company operate into various departments like Cardiology Department; Casualty Department; Diagnostic Services; Intensive Care Unit; Nephrology Department and Physiotherapy Department.
About Dolphin Medical Services Ltd
Dolphin Medical Services Limited, established in September, 1992 is an organization promoted by the doctors from the coastal region of Andhra Pradesh.
The Chief Promoters are Dr. M. S. S. Koteswara Rao, an eminent physician and former Minister for Health in Andhra Pradesh and Dr. G. V. Mohan Prasad, a Radiologist cum ENT specialist.
The Company has been providing comprehensive Diagnostic Services since 1994, with a range of tests covering Radiology and Imaging, Biochemistry, Pathology and Microbiology etc., to the people of the coastal region of Andhra Pradesh.
The Company was able to withstand the tough competition in the market and still enhance its profitability of the Company.
The present status of the Company is that the Company was debt free and later made profit making for past many years.
FAQs for the comparison of Chennai Meenakshi Multispeciality Hospital Ltd and Dolphin Medical Services Ltd
Which company has a larger market capitalization, Chennai Meenakshi Multispeciality Hospital Ltd or Dolphin Medical Services Ltd?
Market cap of Chennai Meenakshi Multispeciality Hospital Ltd is 24 Cr while Market cap of Dolphin Medical Services Ltd is 10 Cr
What are the key factors driving the stock performance of Chennai Meenakshi Multispeciality Hospital Ltd and Dolphin Medical Services Ltd?
The stock performance of Chennai Meenakshi Multispeciality Hospital Ltd and Dolphin Medical Services Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.
What are the recent stock price for Chennai Meenakshi Multispeciality Hospital Ltd and Dolphin Medical Services Ltd?
As of November 1, 2026, the Chennai Meenakshi Multispeciality Hospital Ltd stock price is INR ₹33.15. On the other hand, Dolphin Medical Services Ltd stock price is INR ₹6.78.
How do dividend payouts of Chennai Meenakshi Multispeciality Hospital Ltd and Dolphin Medical Services Ltd compare?
To compare the dividend payouts of Chennai Meenakshi Multispeciality Hospital Ltd and Dolphin Medical Services Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.